Observational Study on "Functional Overlay" in Patients With Movement Disorders
Study Details
Study Description
Brief Summary
The goal of this observational study is to learn about functional neurological disorders in patients with common non-functional movement disorders ("functional overlay"). The main questions it aims to answer are:
-
What is the frequency of functional neurological disorders in patients with non-functional movement disorders (functional overlay)?
-
What are the characteristics of functional neurological disorders in patients with non-functional movement disorders?
Participants will be examined clinically and electrophysiologically, the examinations consist of:
-
a neurological examination
-
neuropsychological testing
-
electrophysiological tremor diagnostic
-
questionnaires about psychological, biological and social risk factors
Researchers will compare patients with functional motor disorders to patients wit non-functional movement disorders to see if they differ from each other regarding the functional symptoms.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
Detailed Description
Functional neurological disorders (FND) are common neurological disorders that are present in up to 16% of patients in neurological outpatient clinics. They are associated with a significant reduction in quality of life, can lead to permanent impairment, and have a poor prognosis, especially if the diagnosis is delayed.
FND have multifactorial causes and risk factors, including psychological stressors, childhood trauma, female gender, psychiatric disorders such as depression, anxiety disorder, or post-traumatic stress disorder, and other functional disorders such as irritable bowel syndrome or chronic pain syndrome. Patients with FND often report additional cognitive complaints ("cognitive fog").
A mismatch of various regulatory mechanisms, a disruption of sensory processing and motor output is assumed to be a central part of the pathogenesis. A characteristic feature of FND is a variability of symptoms according to attention. FND can be intensified by increased attention and weakened by distraction. Positive diagnostic criteria for FND have been established recently, so that by definition FND are no longer a diagnosis of exclusion.
The clinical presentations of FND are diverse and include impaired limb movement control, disturbances in vigilance that may be associated with seizures, and non-motor symptoms. FND often coincide and often coexist with pain, fatigue, sleep disorders, and cognitive disorders. Particularly non-motor functional symptoms are highly debilitating for patients.
The coincidence of "organic" neurological disorders and FND in the same patients ("functional overlay") is probably not uncommon, but has been investigated primarily in patients with Parkinson's Disease and epilepsy, so far. However, it is important to recognize FND in patients with movement disorders in order to treat them adequately and to protect them from incorrect treatment (surgery, unnecessary medication, etc.). However, the basic prerequisite for this is an exploration of the frequency and characteristics of the functional symptoms in movement disorders.
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Parkinson Disease
|
Diagnostic Test: Neurological examination
A neurological examination following a protocol to detect positive signs of functional neurological disorders.
Diagnostic Test: Anamnesis
A standardized question about the patient´s history. The response time is measured.
Question: "Could you tell me about the problems with the movement disorder you are experiencing?"
Diagnostic Test: Neuropsychological testing
Neuropsychological cognitive testing including:
Montreal Cognitive Assessment (MOCA)
Rey-Osterrieth Complex Figure Test (ROCFT)
Wechsler Memory Scale IV
Comprehensive Trail Making Test (CTMT)
semantic and phonematic fluency tests
Diagnostic Test: Questionnaires
Short Form 36 (SF 36)
Somatic Symptom Disorder - B Criteria Scale (SSD 12)
Patient Health Questionnaire 9 (PHQ 9)
Patient Health Questionnaire 15 (PHQ 15)
Generalized Anxiety Disorder 7 (GAD 7)
Fatigue Severity Scale (FSS)
Psychosomatic Competence Inventory (PSCI)
Work Ability Index (WAI)
Level of Personality Functioning Scale
Toronto Alexithymia Scale
Levels of Emotional Awareness Scale (short version)
Certainty About Mental States Questionnaire
Somatosensoric Amplification Scale
Personality Inventory for DSM-5 short version (PID5BF+M)
Childhood Trauma Questionnaire
European Quality of Life 5 Dimensions 5 Level Version (EQ5D5L)
Diagnostic Test: Tremor recording
Accelerometry following a standardized protocol, using a triaxial accelerometer transducer (Biometrics ACL300, Sensitivity 6 100 mV/G, Biometrics Ltd, UK)
|
Idiopathic Dystonia
|
Diagnostic Test: Neurological examination
A neurological examination following a protocol to detect positive signs of functional neurological disorders.
Diagnostic Test: Anamnesis
A standardized question about the patient´s history. The response time is measured.
Question: "Could you tell me about the problems with the movement disorder you are experiencing?"
Diagnostic Test: Neuropsychological testing
Neuropsychological cognitive testing including:
Montreal Cognitive Assessment (MOCA)
Rey-Osterrieth Complex Figure Test (ROCFT)
Wechsler Memory Scale IV
Comprehensive Trail Making Test (CTMT)
semantic and phonematic fluency tests
Diagnostic Test: Questionnaires
Short Form 36 (SF 36)
Somatic Symptom Disorder - B Criteria Scale (SSD 12)
Patient Health Questionnaire 9 (PHQ 9)
Patient Health Questionnaire 15 (PHQ 15)
Generalized Anxiety Disorder 7 (GAD 7)
Fatigue Severity Scale (FSS)
Psychosomatic Competence Inventory (PSCI)
Work Ability Index (WAI)
Level of Personality Functioning Scale
Toronto Alexithymia Scale
Levels of Emotional Awareness Scale (short version)
Certainty About Mental States Questionnaire
Somatosensoric Amplification Scale
Personality Inventory for DSM-5 short version (PID5BF+M)
Childhood Trauma Questionnaire
European Quality of Life 5 Dimensions 5 Level Version (EQ5D5L)
Diagnostic Test: Tremor recording
Accelerometry following a standardized protocol, using a triaxial accelerometer transducer (Biometrics ACL300, Sensitivity 6 100 mV/G, Biometrics Ltd, UK)
|
Essential Tremor
|
Diagnostic Test: Neurological examination
A neurological examination following a protocol to detect positive signs of functional neurological disorders.
Diagnostic Test: Anamnesis
A standardized question about the patient´s history. The response time is measured.
Question: "Could you tell me about the problems with the movement disorder you are experiencing?"
Diagnostic Test: Neuropsychological testing
Neuropsychological cognitive testing including:
Montreal Cognitive Assessment (MOCA)
Rey-Osterrieth Complex Figure Test (ROCFT)
Wechsler Memory Scale IV
Comprehensive Trail Making Test (CTMT)
semantic and phonematic fluency tests
Diagnostic Test: Questionnaires
Short Form 36 (SF 36)
Somatic Symptom Disorder - B Criteria Scale (SSD 12)
Patient Health Questionnaire 9 (PHQ 9)
Patient Health Questionnaire 15 (PHQ 15)
Generalized Anxiety Disorder 7 (GAD 7)
Fatigue Severity Scale (FSS)
Psychosomatic Competence Inventory (PSCI)
Work Ability Index (WAI)
Level of Personality Functioning Scale
Toronto Alexithymia Scale
Levels of Emotional Awareness Scale (short version)
Certainty About Mental States Questionnaire
Somatosensoric Amplification Scale
Personality Inventory for DSM-5 short version (PID5BF+M)
Childhood Trauma Questionnaire
European Quality of Life 5 Dimensions 5 Level Version (EQ5D5L)
Diagnostic Test: Tremor recording
Accelerometry following a standardized protocol, using a triaxial accelerometer transducer (Biometrics ACL300, Sensitivity 6 100 mV/G, Biometrics Ltd, UK)
|
Functional Neurological Disorder
|
Diagnostic Test: Neurological examination
A neurological examination following a protocol to detect positive signs of functional neurological disorders.
Diagnostic Test: Anamnesis
A standardized question about the patient´s history. The response time is measured.
Question: "Could you tell me about the problems with the movement disorder you are experiencing?"
Diagnostic Test: Neuropsychological testing
Neuropsychological cognitive testing including:
Montreal Cognitive Assessment (MOCA)
Rey-Osterrieth Complex Figure Test (ROCFT)
Wechsler Memory Scale IV
Comprehensive Trail Making Test (CTMT)
semantic and phonematic fluency tests
Diagnostic Test: Questionnaires
Short Form 36 (SF 36)
Somatic Symptom Disorder - B Criteria Scale (SSD 12)
Patient Health Questionnaire 9 (PHQ 9)
Patient Health Questionnaire 15 (PHQ 15)
Generalized Anxiety Disorder 7 (GAD 7)
Fatigue Severity Scale (FSS)
Psychosomatic Competence Inventory (PSCI)
Work Ability Index (WAI)
Level of Personality Functioning Scale
Toronto Alexithymia Scale
Levels of Emotional Awareness Scale (short version)
Certainty About Mental States Questionnaire
Somatosensoric Amplification Scale
Personality Inventory for DSM-5 short version (PID5BF+M)
Childhood Trauma Questionnaire
European Quality of Life 5 Dimensions 5 Level Version (EQ5D5L)
Diagnostic Test: Tremor recording
Accelerometry following a standardized protocol, using a triaxial accelerometer transducer (Biometrics ACL300, Sensitivity 6 100 mV/G, Biometrics Ltd, UK)
|
Functional Cognitive Disorder
|
Diagnostic Test: Neurological examination
A neurological examination following a protocol to detect positive signs of functional neurological disorders.
Diagnostic Test: Anamnesis
A standardized question about the patient´s history. The response time is measured.
Question: "Could you tell me about the problems with the movement disorder you are experiencing?"
Diagnostic Test: Neuropsychological testing
Neuropsychological cognitive testing including:
Montreal Cognitive Assessment (MOCA)
Rey-Osterrieth Complex Figure Test (ROCFT)
Wechsler Memory Scale IV
Comprehensive Trail Making Test (CTMT)
semantic and phonematic fluency tests
Diagnostic Test: Questionnaires
Short Form 36 (SF 36)
Somatic Symptom Disorder - B Criteria Scale (SSD 12)
Patient Health Questionnaire 9 (PHQ 9)
Patient Health Questionnaire 15 (PHQ 15)
Generalized Anxiety Disorder 7 (GAD 7)
Fatigue Severity Scale (FSS)
Psychosomatic Competence Inventory (PSCI)
Work Ability Index (WAI)
Level of Personality Functioning Scale
Toronto Alexithymia Scale
Levels of Emotional Awareness Scale (short version)
Certainty About Mental States Questionnaire
Somatosensoric Amplification Scale
Personality Inventory for DSM-5 short version (PID5BF+M)
Childhood Trauma Questionnaire
European Quality of Life 5 Dimensions 5 Level Version (EQ5D5L)
Diagnostic Test: Tremor recording
Accelerometry following a standardized protocol, using a triaxial accelerometer transducer (Biometrics ACL300, Sensitivity 6 100 mV/G, Biometrics Ltd, UK)
|
Alzheimer Disease
|
Diagnostic Test: Neurological examination
A neurological examination following a protocol to detect positive signs of functional neurological disorders.
Diagnostic Test: Anamnesis
A standardized question about the patient´s history. The response time is measured.
Question: "Could you tell me about the problems with the movement disorder you are experiencing?"
Diagnostic Test: Neuropsychological testing
Neuropsychological cognitive testing including:
Montreal Cognitive Assessment (MOCA)
Rey-Osterrieth Complex Figure Test (ROCFT)
Wechsler Memory Scale IV
Comprehensive Trail Making Test (CTMT)
semantic and phonematic fluency tests
Diagnostic Test: Questionnaires
Short Form 36 (SF 36)
Somatic Symptom Disorder - B Criteria Scale (SSD 12)
Patient Health Questionnaire 9 (PHQ 9)
Patient Health Questionnaire 15 (PHQ 15)
Generalized Anxiety Disorder 7 (GAD 7)
Fatigue Severity Scale (FSS)
Psychosomatic Competence Inventory (PSCI)
Work Ability Index (WAI)
Level of Personality Functioning Scale
Toronto Alexithymia Scale
Levels of Emotional Awareness Scale (short version)
Certainty About Mental States Questionnaire
Somatosensoric Amplification Scale
Personality Inventory for DSM-5 short version (PID5BF+M)
Childhood Trauma Questionnaire
European Quality of Life 5 Dimensions 5 Level Version (EQ5D5L)
Diagnostic Test: Tremor recording
Accelerometry following a standardized protocol, using a triaxial accelerometer transducer (Biometrics ACL300, Sensitivity 6 100 mV/G, Biometrics Ltd, UK)
|
Outcome Measures
Primary Outcome Measures
- Functional neurological symptoms [on average 30 minutes]
Diagnosed by positive signs for functional neurological symptoms, as assessed in the neurological examination
Secondary Outcome Measures
- Duration of anamnesis [1 to 3 minutes]
Duration in seconds of the response to the question: "Could you tell me about the problems with the movement disorder you are experiencing?"
- Tremor diagnostic [up to 20 minutes]
Sum score of a electrophysiological test battery for psychogenic tremor, a scale from 0 to 10 with higher numbers indicating a higher probability for functional tremor
- Subjective quality of life [5 minutes]
European Quality of Life 5 Dimensions 5 Level Version (EQ 5D 5L), results in a 5-digit number that describes the patient's health state
- Subjective health [up to 10 minutes]
Short Form 36 Questionnaire (SF-36), a 36 items questionnaires that results in 8 scales that describe the subjective health state of the patient, higher values indicating better health
- Fatigue [up to 5 minutes]
Fatigue severity scale (FSS): 9 item questionnaire with a 7 point Likert scale, higher values indicating more fatigue
- General anxiety [3 minutes]
General anxiety disorder scale 7 (GAD-7): a 7 items questionnaire (0 to 21 points, higher values indicating more anxiety)
- Somatic symptoms [5 minutes]
Patient health questionnaire 15 (PHQ 15): a 15 item questionnaire (0 to 30 points, higher values indicating more somatic symptoms)
- Depression [3 minutes]
Patient health questionnaire 9 (PHQ 9): a 9 item questionnaire (0 to 27 points, higher values indicating more depressive symptoms)
- Psychosomatic Competence [up to 10 minutes]
Psychosomatic Competence Inventory (PSCI): a 44 items questionnaire with a 6 point Likert scale, resulting in 6 subscales, higher values indicate higher psychosomatic competence
- Work ability [5 minutes]
Work ability index (WAI): 7 item questionnaire, 7 to 49 points, with higher values indicating better work ability
- Trauma in childhood [up to 10 minutes]
Child Trauma Questionnaire (CTQ): 28 items questionnaire, 5 point Likert scale, resulting in 5 subscales with 5 to 25 points, with higher values indicating more trauma experience
- Attachment styles [5 minutes]
Experience of Close Relationships-Revised (ECR-RD 12): 12 items questionnaire with a 7 point Likert scale, resulting in 2 subscales
- Alexithymia [5 minutes]
Toronto alexithymia scale (TAS): 26 items questionnaire with a 5 point Likert scale, higher values indicating more alexithymia
- Personality traits [up to 10 minutes]
The Personality Inventory for DSM-5 and ICD-11 Plus Modified (PID5BF + M): a 36 items questionnaire, with a 4 point Likert scale, resulting in 6 subscales
- Personality functioning [up to 15 minutes]
Levels of personality functioning scale (LPFS): a 80 items questionnaire, with a 4 point Likert scale, resulting in 4 subscales
- Executive function [up to 10 minutes]
Comprehensive trail making test (CTMT)
- Memory [up to 15 minutes]
Wechsler Memory Scale
- Visuospatial abilities [up to 15 minutes]
Rey-Osterrieth complex figure test
- Functional cognitive symptoms [up to 60 minutes]
Incongruence in cognitive tests
- Semantic word fluency [2 minutes]
number of animals that can be listed in 2 minutes
- phonematic word fluency [2 minutes]
number of words, that start with the letter "b", that can be listed in 2 minutes
Eligibility Criteria
Criteria
Inclusion Criteria:
-
Functional or non-functional movement disorder
-
18 to 80 years
Exclusion Criteria:
-
Patient is not able to consent
-
Patient is not able to understand / speak German fluently (questionnaires are available only in German)
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | Medical University of graz | Graz | Styria | Austria | 8010 |
Sponsors and Collaborators
- Medical University of Graz
Investigators
None specified.Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- 34-509 ex 21/22